XOMA Royalty to Present at Upcoming Investor Conferences in September
XOMA Royalty (NASDAQ: XOMA), a biotech royalty aggregator, has announced its participation in two major investor conferences in September 2024. The company's executive team, including CEO Owen Hughes and CIO Brad Sitko, will present corporate overviews at:
1. The H.C. Wainwright 26th Annual Global Investment Conference in New York, NY (September 9-11, 2024). Presentation scheduled for September 9 at 9:00 AM ET.
2. The 2024 Cantor Global Healthcare Conference in New York, NY (September 17-19, 2024). Presentation scheduled for September 17 at 2:30 PM ET.
Both presentations will be accessible via provided links and through XOMA's investor relations website. Replays will be available for 90 days after each event.
XOMA Royalty (NASDAQ: XOMA), un aggregatore di royalty nel settore biotech, ha annunciato la sua partecipazione a due importanti conferenze per investitori a settembre 2024. Il team esecutivo dell'azienda, compresi CEO Owen Hughes e CIO Brad Sitko, presenterà una panoramica aziendale presso:
1. La 26ª Conferenza Globale di Investimento Annuale H.C. Wainwright a New York, NY (9-11 settembre 2024). La presentazione è programmata per il 9 settembre alle 9:00 AM ET.
2. La Conferenza Globale sulla Salute 2024 di Cantor a New York, NY (17-19 settembre 2024). La presentazione è programmata per il 17 settembre alle 2:30 PM ET.
Entrambe le presentazioni saranno accessibili tramite i link forniti e attraverso il sito web delle relazioni con gli investitori di XOMA. Le registrazioni saranno disponibili per 90 giorni dopo ciascun evento.
XOMA Royalty (NASDAQ: XOMA), un agregador de regalías en el sector biotecnológico, ha anunciado su participación en dos conferencias importantes para inversores en septiembre de 2024. El equipo ejecutivo de la compañía, que incluye a CEO Owen Hughes y CIO Brad Sitko, presentará una visión general de la empresa en:
1. La 26ª Conferencia Anual Global de Inversión H.C. Wainwright en Nueva York, NY (del 9 al 11 de septiembre de 2024). La presentación está programada para el 9 de septiembre a las 9:00 AM ET.
2. La Conferencia Global de Atención Médica 2024 de Cantor en Nueva York, NY (del 17 al 19 de septiembre de 2024). La presentación está programada para el 17 de septiembre a las 2:30 PM ET.
Ambas presentaciones estarán accesibles a través de los enlaces proporcionados y en el sitio web de relaciones con inversores de XOMA. Las repeticiones estarán disponibles durante 90 días después de cada evento.
XOMA Royalty (NASDAQ: XOMA), 생명공학 로열티 집합체,는 2024년 9월 두 가지 주요 투자자 회의에 참여한다고 발표했습니다. CEO Owen Hughes와 CIO Brad Sitko를 포함한 회사의 경영진이 다음의 기업 개요를 발표할 예정입니다:
1. H.C. Wainwright 제26회 연례 글로벌 투자 컨퍼런스가 뉴욕, NY에서 (2024년 9월 9-11일). 발표는 9월 9일 오전 9:00 ET로 예정되어 있습니다.
2. 2024 Cantor 글로벌 헬스케어 컨퍼런스가 뉴욕, NY에서 (2024년 9월 17-19일). 발표는 9월 17일 오후 2:30 ET로 예정되어 있습니다.
두 발표 모두 제공된 링크를 통해 그리고 XOMA의 투자자 관계 웹사이트를 통해 접근할 수 있습니다. 각 이벤트 후 90일 동안 반복 시청이 가능합니다.
XOMA Royalty (NASDAQ: XOMA), un agrégateur de redevances biopharmaceutiques, a annoncé sa participation à deux grandes conférences pour investisseurs en septembre 2024. L'équipe dirigeante de l'entreprise, y compris le PDG Owen Hughes et le CIO Brad Sitko, présentera des aperçus d'entreprise lors de :
1. La 26ème Conférence Annuelle Mondiale sur l'Investissement H.C. Wainwright à New York, NY (du 9 au 11 septembre 2024). La présentation est prévue pour le 9 septembre à 9h00 ET.
2. La Conférence Mondiale de la Santé 2024 de Cantor à New York, NY (du 17 au 19 septembre 2024). La présentation est prévue pour le 17 septembre à 14h30 ET.
Les deux présentations seront accessibles via les liens fournis et sur le site web des relations investisseurs de XOMA. Les rediffusions seront disponibles pendant 90 jours après chaque événement.
XOMA Royalty (NASDAQ: XOMA), ein Biotech-Royalty-Aggregator, hat seine Teilnahme an zwei großen Investorenkonferenzen im September 2024 bekannt gegeben. Das Führungsteam des Unternehmens, darunter CEO Owen Hughes und CIO Brad Sitko, wird Unternehmensübersichten präsentieren bei:
1. Der 26. Jahrestagung H.C. Wainwright Global Investment Conference in New York, NY (9.-11. September 2024). Die Präsentation ist für den 9. September um 9:00 Uhr ET angesetzt.
2. Der 2024 Cantor Global Healthcare Conference in New York, NY (17.-19. September 2024). Die Präsentation ist für den 17. September um 14:30 Uhr ET angesetzt.
Beide Präsentationen sind über die bereitgestellten Links und über die Investor Relations-Website von XOMA zugänglich. Aufzeichnungen werden für 90 Tage nach jeder Veranstaltung verfügbar sein.
- None.
- None.
EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following September 2024 investor conferences:
- H.C. Wainwright 26th Annual Global Investment Conference taking place September 9-11, 2024, in New York, NY. Owen Hughes, Chief Executive Officer, and Brad Sitko, Chief Investment Officer, will present a corporate overview on Monday, September 9, 2024, at 9:00 AM ET. The presentation can be accessed at https://bit.ly/4coqH9K.
- 2024 Cantor Global Healthcare Conference, which is being held September 17-19, 2024, in New York, NY. Mr. Hughes and Mr. Sitko will present a corporate overview on September 17, 2024, at 2:30 PM ET. The presentation can be accessed at https://bit.ly/3yNkp5U.
XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com. A replay of each presentation will be available and archived on the site for 90 days after the event.
About XOMA Royalty Corporation
XOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA Royalty acquires the potential future economics associated with pre-commercial and commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA Royalty acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes. The Company has an extensive and growing portfolio of assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate). For more information about the Company and its portfolio, please visit www.xoma.com or follow XOMA Royalty Corporation on LinkedIn.
| XOMA Investor Contact Juliane Snowden XOMA Royalty +1 646-438-9754 juliane.snowden@xoma.com | XOMA Media Contact Kathy Vincent KV Consulting & Management +1 310-403-8951 kathy@kathyvincent.com |
FAQ
When and where will XOMA Royalty present at the H.C. Wainwright Global Investment Conference in 2024?
Who will be presenting on behalf of XOMA at the September 2024 investor conferences?
What is the date and time of XOMA's presentation at the 2024 Cantor Global Healthcare Conference?
How long will the replays of XOMA's presentations be available on their website?
What is XOMA's stock symbol and where is it traded?
